MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511122439 A) filed by Dr. Pawan Singh, Moradabad, Uttar Pradesh, on Dec. 5, 2025, for 'novel bioactive phyto-synthetic formulations and their pharmacological applications in drug delivery systems.'
Inventor(s) include Dr. Pawan Singh; Ms. Rachana Belwal; Ms. Priya Pandey; Dr. Vipin Kumar Sharma; Dr. Hemendra Gautam; Dr. Pragya Prashant Gupta; Dr. Jatin Jaiswal; Dr. Gyanendra Kumar Sharma; Ms. Malavika P. S; Ms. Santoshi Shah; Mr. Shobhit Sharma; and Dr. Javed Siddiqui.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel bioactive phyto-synthetic formulations comprising plant-derived bioactive compounds integrated with synthetic polymeric carriers for enhanced drug delivery systems. The formulations utilize phytochemicals extracted from medicinal plants combined with biodegradable synthetic polymers to create hybrid nano-particulate systems exhibiting superior bioavailability, controlled release kinetics, and targeted therapeutic action. The invention encompasses methods of preparing these formulations through green synthesis techniques, resulting in stable colloidal dispersions with particle sizes ranging from 50 to 500 nanometers. The phyto-synthetic composites demonstrate enhanced solubility of hydrophobic drugs, improved cellular uptake, reduced toxicity, and prolonged circulation time in biological systems. The formulations find applications in treating various diseases including cancer, diabetes, inflammatory disorders, and microbial infections. The invention provides pharmaceutical compositions with improved therapeutic efficacy compared to conventional drug delivery systems while maintaining biocompatibility and environmental sustainability through the use of natural plant-based components and biodegradable synthetic materials."
Disclaimer: Curated by HT Syndication.
